BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37015073)

  • 1. Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers.
    Yun SY; Rim JH; Park H; Kang H; Lee SG; Lim JB
    Clin Chem Lab Med; 2023 Jun; 61(7):1288-1299. PubMed ID: 37015073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
    Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
    Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Long-Term Storage on Serum Free Light Chain Stability.
    Hörber S; Klein R; Peter A
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPA
    White-Al Habeeb NMA; Earle T; Spencer M; Blasutig IM
    Clin Biochem; 2018 Jan; 51():90-96. PubMed ID: 28512013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment.
    Rollborn N; Jakobsson J; Campbell A; Nordin G; Karlsson M; Larsson A; Kultima K
    Clin Biochem; 2023 Jan; 111():47-53. PubMed ID: 36241061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy.
    Kim HS; Kim HS; Shin KS; Song W; Kim HJ; Kim HS; Park MJ
    Biomed Res Int; 2014; 2014():647238. PubMed ID: 24971342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance Evaluation of Serum Free Light Chain Analysis: Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents.
    Messiaen AS; De Sloovere MMW; Claus PE; Vercammen M; Van Hoovels L; Heylen O; Debrabandere J; Vanpoucke H; De Smet D
    Am J Clin Pathol; 2017 Jun; 147(6):611-622. PubMed ID: 28575180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay.
    Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA
    Pathology; 2015 Oct; 47(6):564-9. PubMed ID: 26352111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two Serum Free Light Chain Detection Systems in the Diagnosis of Multiple Myeloma].
    Zhu GQ; Fu X; Ren YS; Wang YS; Wang SL; Wang LC; Lin J; An G
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1209-1215. PubMed ID: 34362504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays.
    Moreau C; Autier B; Cavey T; Rouger E; Norwood J; Bendavid C; Escoffre M; Sébillot M; Decaux O
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):693-704. PubMed ID: 27618362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
    Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
    J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Freelite and N-Latex serum free light chain assays: a critical review.
    Daves M; Piccin A; Roccaforte V; Lippi G
    Biochem Med (Zagreb); 2021 Oct; 31(3):030701. PubMed ID: 34393594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer.
    Augustijn D; Jacobs JFM; Russcher H
    Clin Chem Lab Med; 2022 Feb; 60(3):379-385. PubMed ID: 34969184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots.
    Pretorius CJ; Klingberg S; Tate J; Wilgen U; Ungerer JP
    Ann Clin Biochem; 2012 Sep; 49(Pt 5):450-5. PubMed ID: 22764186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
    Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
    Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
    Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
    Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis.
    Kennard A; Hawley C; Tate J; Klingberg S; Pretorius C; Hutchison C; Mollee P
    Clin Chem Lab Med; 2016 Jun; 54(6):1045-52. PubMed ID: 26684350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N Latex FLC - new monoclonal high-performance assays for the determination of free light chain kappa and lambda.
    Velthuis HT; Knop I; Stam P; van den Broek M; Bos HK; Hol S; Teunissen E; Fischedick KS; Althaus H; Schmidt B; Wagner C; Melsert R
    Clin Chem Lab Med; 2011 Aug; 49(8):1323-1332. PubMed ID: 21663464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum free light chain analysis: persisting limitations with new kids on the block.
    Van Hoovels L; Vercammen M; Nevejan L; Cornette M; Briers PJ; Deeren D; Van Droogenbroeck J; Fostier K; De Smet D
    Clin Chem Lab Med; 2022 Aug; 60(9):1440-1448. PubMed ID: 35781357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Free Light Chain Quantification Testing: Comparison of Two Methods for Disease Monitoring.
    Singh G; Whitaker BM; Wu AHB; Xu H; Bollag RJ
    J Appl Lab Med; 2022 Oct; 7(6):1290-1301. PubMed ID: 36006797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.